References

Ahmet, Z., Warren, M. and Huoang, E.T. (1995) Species identification of members of the Streptococcus milleri group isolated from the vagina by ID

32 Strep System and differential phenotypic characteristics. Journal of Clinical Microbiology, 33, 1592-1595.

Alcaide, F., Linares, J., Pallares, R. etal. (1995) In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrobial Agents and Chemotherapy, 39, 2243-2247.

Alcaide, F., Carratala, J., Linares, J. etal. (1996) In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients. Antimicrobial Agents and Chemotherapy, 40, 2117-2120.

Banks, J., Poole, S., Nair, S.P. etal. (2002) Streptococcus sanguis secretes CD14-binding proteins that stimulate cytokine synthesis: a clue to the pathogenesis of infective (bacterial) endocarditis? Microbial Pathogenesis, 32, 105-116.

Barnard, J.P. and Stinson, M.W. (1996) The alpha-hemolysin of Streptococcus gordonii is hydrogen peroxide. Infection and Immunity, 64, 3853-3857.

Barnard, J.P. and Stinson, M.W. (1999) Influence of environmental conditions on hydrogen peroxide formation by Streptococcus gordonii. Infection and Immunity, 67, 6558-6564.

Bayer, A.S., Ward, J.I., Ginzton, L.E. and Shapiro, S.M. (1994) Evaluation of new clinical criteria for the diagnosis of infective endocarditis. The American Journal of Medicine, 96, 211-219.

Bayer, A.S., Bolger, A.F., Taubert, K.A. etal. (1998) Diagnosis and management of infective endocarditis and its complications. Circulation, 98, 2936-2948.

Belko, J., Goldmann, D.A., Macone, A. and Zaidi, A.K. (2002) Clinically significant infections with organisms of the Streptococcus milleri group. The Pediatric Infectious Disease Journal, 21, 715-723.

Bensing, B.A., Rubens, C.E. and Sullam, P.M. (2001) Genetic loci of Streptococcus mitis that mediate binding to human platelets. Infection and Immunity, 69, 1373-1380.

Bensing, B.A., Siboo, I.R. and Sullam, P.M. (2001) Proteins PblA and PblB of Streptococcus mitis, which promote binding to human platelets, are encoded within a lysogenic bacteriophage. Infection and Immunity, 69, 6186-6192.

Bentley, R.W., Leigh, J.A. and Collins, M.D. (1991) Intrageneric structure of Streptococcus based on comparative analysis of small-subunit rRNA sequences. International Journal of Systematic Bacteriology, 41, 487-494.

Billington, S.J., Jost, B.H. and Songer, J.G. (2000) Thiol-activated cytolysins: structure, function and role in pathogenesis. FEMS Microbiology Letters, 182, 197-205.

Bourgault, A.M., Wilson, W.R. and Washington, J.A. (1979) Antimicrobial susceptibilities of species of viridans streptococci. The Journal of Infectious Diseases, 140, 316-321.

Bouvet, A., Grimont, F. and Grimont, P.A.D. (1989) Streptococcus defectivus sp. nov. and Streptococcus adjacens sp. nov. nutritionally variant streptococci from human clinical specimens. International Journal of Systematic Bacteriology, 39, 290-294.

Burnette-Curley, D., Wells, V., Viscount, H. etal. (1995) FimA, a major virulence factor associated with Streptococcus parasanguis endocarditis. Infection and Immunity, 63, 4669-4674.

Carratala, J., Alcaide, F., Fernandez-Sevilla, A. etal. (1995) Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer. Clinical Infectious Diseases, 20, 1169-1173.

Casariego, E., Rodriguez, A., Corredoira, J.C. etal. (1996) Prospective study of Streptococcus milleri bacteremia. European Journal of Clinical Microbiology & Infectious Diseases, 15, 194-200.

Christie, J., McNab, R. and Jenkinson, H.F. (2002) Expression of fibronectin-binding protein FbpA modulates adhesion in Streptococcus gordonii. Microbiology, 148, 1615-1625.

Clarke, J.K. (1924) On the bacterial factor in the aetiology of dental caries. British Journal of Experimental Pathology, 5, 141-147.

Collins, M.D., Lawson, P.A. (2000) The genus Abiotrophia (Kawamura et al.) is not monophyletic: proposal of Granulicatella gen. nov., Granulicatella adiacens comb. nov., Granulicatella elegans comb. nov. and Granulicatella balaenopterae comb. nov. International Journal of Systematic and Evolutionary Microbiology, 50, 365-369.

Dankert, J., van der Werff, J., Zaat, S.A. etal. (1995) Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis. Infection and Immunity, 63, 663-671.

Dankert, J., Krijgsveld, J., van Der Werff, J. etal. (2001) Platelet microbicidal activity is an important defense factor against viridans streptococcal endocarditis. The Journal of Infectious Diseases, 184, 597-605.

de Azavedo, J.C., Trpeski, L., Pong-Porter, S. etal. (1999) In vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada. Antimicrobial Agents and Chemotherapy, 43, 2299-2301.

De Gheldre, Y., Vandamme, P., Goossens, H. and Struelens, M.J. (1999) Identification of clinically relevant viridans streptococci by analysis of transfer DNA intergenic spacer length polymorphism. International Journal of Systematic Bacteriology, 49, 1591-1598.

Diekema, D.J., Pfaller, M.A., Jones, R.N. etal. (2000) Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group. International Journal of Antimicrobial Agents, 13, 257-271.

Doern, G.V., Ferraro, M.J., Brueggemann, A.B. and Ruoff, K.L. (1996) Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrobial Agents and Chemotherapy, 40, 891-894.

Douglas, C.W., Brown, P.R. and Preston, F.E. (1990) Platelet aggregation by oral streptococci. FEMS Microbiology Letters, 72, 63-68.

Douglas, C.W., Heath, J., Hampton, K.K. and Preston, F.E. (1993) Identity of viridans streptococci isolated from cases of infective endocarditis. Journal of Medical Microbiology, 39, 179-182.

Durack, D.T. (1998) Antibiotics for prevention of endocarditis during dentistry: time to scale back? Annals of Internal Medicine, 129, 829-831.

Durack, D.T., Lukes, A.S. and Bright, D.K. (1994) New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. The American Journal of Medicine, 96, 200-209.

Duval, X., Papastamopoulos, V., Longuet, P. etal. (2001) Definite Streptococcus bovis endocarditis: characteristics in 20 patients. Clinical Microbiology and Infection, 7, 3-10.

Elliott, D., Harrison, E., Handley, P.S. etal. (2003) Prevalence of Csh-like fibrillar surface proteins among mitis group oral streptococci. Oral Microbiology and Immunology, 18, 114-120.

Emori, T.G. and Gaynes, R.P. (1993) An overview of nosocomial infections, including the role of the microbiology laboratory. Clinical Microbiology Reviews, 6, 428-442.

Facklam, R. (2002) What happened to the streptococci: overview of taxonomic and nomenclature changes. Clinical Microbiology Reviews, 15, 613-630.

Ferrieri, P., Gewitz, M.H., Gerber, M.A. etal. (2002) Unique features of infective endocarditis in childhood. Circulation, 105, 2115-2127.

Fluit, A.C., Jones, M.E., Schmitz, F.J. etal. (2000) Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. Clinical Infectious Diseases, 30, 454-460.

Freney, J., Bland, S., Etienne, J. etal. (1992) Description and evaluation of the semiautomated 4-hour Rapid ID 32 Strep method for identification of streptococci and members of related genera. Journal of Clinical Microbiology, 30, 2657-2661.

Gershon, A.S., de Azavedo, J.C., McGeer, A. etal. (2002) Activities of new fluoroquinolones, ketolides, and other antimicrobials against blood culture isolates of viridans group streptococci from across Canada, 2000. Antimicrobial Agents and Chemotherapy, 46, 1553-1556.

Gordon, K.A., Beach, M.L., Biedenbach, D.J. etal. (2002) Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagnostic Microbiology and Infectious Disease, 43, 157-162.

Hall, G., Heimdahl, A. and Nord, C.E. (1999) Bacteremia after oral surgery and antibiotic prophylaxis for endocarditis. Clinical Infectious Diseases, 29, 1-8.

Hamada, S. and Slade, H.D. (1980) Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiological Reviews, 44, 331-384.

Hardie, J.M. and Whiley, R.A. (1992) The genus Streptococcus - oral. In The Prokaryotes, 2nd edn, Vol. II (eds A. Balows, H.G. Trüper, M. Dworkin, W. Harder and K.-H. Schleifer), pp. 1421-1449. Springer-Verlag, New York.

Hardie, J.M. and Whiley, R.A. (1994) Recent developments in streptococcal taxonomy: their relation to infections. Reviews in Medical Microbiology, 5, 151-162.

Herzberg, M.C. (1996) Platelet-streptococcal interactions in endocarditis. Critical Reviews in Oral Biology and Medicine, 7, 222-236.

Herzberg, M.C., MacFarlane, G.D., Gong, K. etal. (1992) The platelet interactivity phenotype of Streptococcus sanguis influences the course of experimental endocarditis. Infection and Immunity, 60, 4809-4818.

Herzberg, M.C., Meyer, M.W., Kili§, A.O. and Tao, L. (1997) Host-pathogen interactions in bacterial endocarditis: streptococcal virulence in the host. Advances in Dental Research, 11, 69-74.

Hillman, J.D. (2002) Genetically modified Streptococcus mutans for the prevention of dental caries. Antonie van Leeuwenhoek, 82, 361-366.

Hoen, B., Alla, F., Selton-Suty, C. etal. (2002) Changing profile of infective endocarditis: results of a 1-year survey in France. Journal of the American Medical Association, 288, 75-81.

Hogevik, H., Olaison, L., Andersson, R. etal. (1995) Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study. Medicine (Baltimore), 74, 324-339.

HPA (2002) Candidaemia and polymicrobial bacteraemias, England, Wales, and Northern Ireland 2002. CDR Weekly [Serial Online], 13. http:// www.hpa.org.uk/cdr/PDFfiles/2003/cdr4203.pdf (10 February 2004).

HPA (2003a) Pyogenic and non-pyogenic streptococcal bacteraemias, England, Wales, and Northern Ireland 2002. CDR Weekly, 13(16). www.hpa.org.uk/cdr/PDFfiles/2003/cdr1603.pdf (10 February 2004).

HPA (2003b) Klebsiella, Enterobacter, Serratia, and Citrobacter spp bacter-aemias, England, Wales, and Northern Ireland 2002. CDR Weekly, 13(20). www.hpa.org.uk/cdr/archives/2003/cdr2003.pdf (10 February 2004).

Jacobs, J.A., Schouten, H.C., Stobberingh, E.E. and Soeters, P.B. (1995) Viridans streptococci isolated from the bloodstream. Relevance of species identification. Diagnostic Microbiology and Infectious Disease, 22, 267-273.

Jacobs, J.A., Schot, C.S. and Schouls, L.M. (2000) Haemolytic activity of the 'Streptococcus milleri group' and relationship between haemolysis restricted to human red blood cells and pathogenicity in S. intermedius. Journal of Medical Microbiology, 49, 55-62.

Jacobs, J.A. and Stobberingh, E.E. (1995) Hydrolytic enzymes of Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius in relation to infection. European Journal of Clinical Microbiology & Infectious Diseases, 14, 818-820.

Johnson, A.P., Warner, M., Broughton, K. etal. (2001) Antibiotic susceptibility of streptococci and related genera causing endocarditis: analysis of UK reference laboratory referrals, January 1996 to March 2000. BMJ (Clinical Research Ed. ), 322, 395-396.

Kawabata, S., Kunitomo, E., Terao, Y. etal. (2001) Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice. Infection and Immunity, 69, 924-930.

Kawamura, Y., Hou, X.G., Sultana, F. etal. (1995a) Determination of 16S rRNA sequences of Streptococcus mitis and Streptococcus gordonii and phylogenetic relationships among members of the genus Streptococcus. International Journal of Systematic Bacteriology, 45, 406-408.

Kawamura, Y., Hou, X.G., Sultana, F. etal. (1995b) Transfer of Streptococcus adjacens and Streptococcus defectivus to Abiotrophia gen. nov. as Abiotrophia adiacens comb. nov. and Abiotrophia defectiva comb. nov., respectively. International Journal of Systematic Bacteriology, 45, 798-803.

Kawamura, Y., Hou, X.G., Todome, Y. etal. (1998) Streptococcusperoris sp. nov. and Streptococcus infantis sp. nov., new members of the Streptococcus mitis group, isolated from human clinical specimens. International Journal of Systematic Bacteriology, 48, 921-927.

Kelly, C.G., Younson, J.S., Hikmat, B.Y. etal. (1999) A synthetic peptide adhesion epitope as a novel antimicrobial agent. Nature Biotechnology, 17, 42-47.

Kennedy, H.F. and Smith, A.J. (2000) Viridans streptococcal infection in the medically compromised. Reviews in Medical Microbiology, 11, 77-86.

Kikuchi, K., Enari, T., Totsuka, K. and Shimizu, K. (1995) Comparison of phenotypic characteristics, DNA-DNA hybridization results, and results with a commercial rapid biochemical and enzymatic reaction system for identification of viridans group streptococci. Journal of Clinical Microbiology, 33, 1215-1222.

Kilian, M. (2001) Recommended conservation of the names Streptococcus sanguis, Streptococcus rattus, Streptococcus cricetus, and seven other names included in the Approved Lists of Bacterial Names. Request for an opinion. International Journal of Systematic and Evolutionary Microbiology, 51, 723-724.

Kilian, M., Mikkelsen, L. and Henrichsen, J. (1989) Taxonomic study of viridans streptococci: description of Streptococcus gordonii sp. nov. and emended descriptions of Streptococcus sanguis (White and Niven 1946), Streptococcus oralis (Bridge and Sneath 1982), and Streptococcus mitis (Andrewes and Horder, 1906). International Journal of Systematic Bacteriology, 39, 471-484.

Kilig, A.O., Herzberg, M.C., Meyer, M.W. etal. (1999) Streptococcal reporter gene-fusion vector for identification of in vivo expressed genes. Plasmid, 42, 67-72.

Kitada, K., Nagata, K., Yakushiji, T. etal. (1992) Serological and biological characteristics of "Streptococcus milleri" isolates from systemic purulent infections. Journal of Medical Microbiology, 36, 143-148.

Kitada, K., Inoue, M. and Kitano, M. (1997) Experimental endocarditis induction and platelet aggregation by Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius. FEMS Immunology and Medical Microbiology, 19, 25-32.

Kitten, T., Munro, C.L., Wang, A. and Macrina, F.L. (2002) Vaccination with FimA from Streptococcus parasanguis protects rats from endocarditis caused by other viridans streptococci. Infection and Immunity, 70, 422-425.

Koga, T., Oho, T., Shimazaki, Y. and Nakano, Y. (2002) Immunization against dental caries. Vaccine, 20, 2027-2044.

Kolenbrander, P.E., Andersen, R.N., Baker, R.A. and Jenkinson, H.F. (1998) The adhesion-associated sca operon in Streptococcus gordonii encodes an inducible high-affinity ABC transporter for Mn2 + uptake. Journal of Bacteriology, 180, 290-295.

Kugler, K.C., Denys, G.A., Wilson, M.L. and Jones, R.N. (2000) Serious streptococcal infections produced by isolates resistant to streptogramins (quinupristin/dalfopristin): case reports from the SENTRY antimicrobial surveillance program. Diagnostic Microbiology and Infectious Disease, 36, 269-272.

Kuramitsu, H.K. (2003) Molecular genetic analysis of the virulence of oral bacterial pathogens: an historical perspective. Critical Reviews in Oral Biology and Medicine, 14, 331-344.

Lee, R.A., Woo, P.C., To, A.P. etal. (2003) Geographical difference of disease association in Streptococcus bovis bacteraemia. Journal of Medical Microbiology, 52, 903-908.

Lefort, A., Lortholary, O., Casassus, P. etal. (2002) Comparison between adult endocarditis due to beta-hemolytic streptococci (serogroups A, B, C, and G) and Streptococcus milleri: a multicenter study in France. Archives of Internal Medicine, 162, 2450-2456.

Lisby, G., Gutschik, E. and Durack, D.T. (2002) Molecular methods for diagnosis of infective endocarditis. Infectious Disease Clinics of North America, 16, 393-412.

Lockhart, P.B. and Durack, D.T. (1999) Oral microflora as a cause of endocarditis and other distant site infections. Infectious Disease Clinics of North America, 13, 833-850.

Lowrance, J.H., Baddour, L.M. and Simpson, W.A. (1990) The role of fibronectin binding in the rat model of experimental endocarditis caused by Streptococcus sanguis. The Journal of Clinical Investigation, 86, 7-13.

Macey, M.G., Whiley, R.A., Miller, L. and Nagamune, H. (2001) Effect on polymorphonuclear cell function of a human-specific cytotoxin, inter-medilysin, expressed by Streptococcus intermedius. Infection and Immunity, 69, 6102-6109.

Marron, A., Carratala, J., Alcaide, F. etal. (2001) High rates of resistance to cephalosporins among viridans-group streptococci causing bacteraemia in neutropenic cancer patients. The Journal of Antimicrobial Chemotherapy, 47, 87-91.

Marsh, P.D. (2003) Are dental diseases examples of ecological catastrophes? Microbiology, 149, 279-294.

McNab, R., Holmes, A.R., Clarke, J.M. etal. (1996) Cell surface polypep-tide CshA mediates binding of Streptococcus gordonii to other oral bacteria and to immobilized fibronectin. Infection and Immunity, 64, 4204-4210.

McWhinney, P.H., Patel, S., Whiley, R.A. etal. (1993) Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin. Antimicrobial Agents and Chemotherapy, 37, 2493-2495.

Morris, A.M. and Webb, G.D. (2001) Antibiotics before dental procedures for endocarditis prophylaxis: back to the future. Heart, 86, 3-4.

Mouly, S., Ruimy, R., Launay, O. etal. (2002) The changing clinical aspects of infective endocarditis: descriptive review of 90 episodes in a French teaching hospital and risk factors for death. The Journal of Infection, 45, 246-256.

Mouton, J.W., Endtz, H.P., den Hollander, J.G. etal. (1997) In-vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with endocarditis. The Journal of Antimicrobial Chemotherapy, 39(Suppl. A), 75-80.

Munro, C.L. and Macrina, F.L. (1993) Sucrose-derived exopolysaccharides of Streptococcus mutans V403 contribute to infectivity in endocarditis. Molecular Microbiology, 8, 133-142.

Mylonakis, E. and Calderwood, S.B. (2001) Infective endocarditis in adults. The New England Journal of Medicine, 345, 1318-1330.

Nagamune, H., Ohnishi, C., Katsuura, A. etal. (1996) Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess. Infection and Immunity, 64, 3093-3100.

Nagamune, H., Whiley, R.A., Goto, T. et al. (2000) Distribution of the inter-medilysin gene among the anginosus group streptococci and correlation between intermedilysin production and deep-seated infection with Streptococcus intermedius. Journal of Clinical Microbiology, 38, 220-226.

Nagashima, H., Takao, A. and Maeda, N. (1999) Abscess forming ability of Streptococcus milleri group: synergistic effect with Fusobacterium nucle-atum. Microbiology and Immunology, 43, 207-216.

NINSS (2003) Surveillance of Hospital-Acquired Bacteraemia in English Hospitals, 1997—2002. PHLS, London. www.hpa.org.uk/infections/ publications/ninns/hosacq_HAB_2002.pdf (10 February 2004).

Petersen, F.C., Pasco, S., Ogier, J. etal. (2001) Expression and functional properties of the Streptococcus intermedius surface protein antigen I/II. Infection and Immunity, 69, 4647-4653.

Petersen, F.C., Assev, S., van der Mei, H.C. etal. (2002) Functional variation of the antigen I/II surface protein in Streptococcus mutans and Streptococcus intermedius. Infection and Immunity, 70, 249-256.

Pfaller, M.A., Jones, R.N., Marshall, S.A. etal. (1997) Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group. Diagnostic Microbiology and Infectious Disease, 29, 259-263.

PHLS (2001) Non-pyogenic and group B streptococcal bacteraemias, England and Wales: 1999 and 2000. CDR Weekly, 11(42). www.hpa.org.uk/cdr/ PDFfiles/2001/cdr4201 .pdf (10 February 2004).

PHLS (2002) Pyogenic and non-pyogenic streptococcal bacteraemias, England and Wales: 2001. CDR Weekly, 12(16). www.hpa.org.uk/cdr/PDFfiles/ 2002/cdr1602.pdf (10 February 2004).

Poyart, C., Pierre, C., Quesne, G. etal. (1997) Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis. Antimicrobial Agents and Chemotherapy, 41, 24-29.

Poyart, C., Quesne, G. and Trieu-Cuot, P. (1998) Taxonomic dissection of the Streptococcus bovis group by analysis of manganese-dependent superoxide dismutase gene (sodA) sequences: reclassification of 'Streptococcus infantarius subsp. coli as Streptococcus lutetiensis sp. nov. and of

Streptococcus bovis biotype II.2 as Streptococcus pasteurianus sp. nov. International Journal of Systematic and Evolutionary Microbiology, 52, 1247-1255.

Renneberg, J., Niemann, L.L. and Gutschik, E. (1997) Antimicrobial susceptibility of 278 streptococcal blood isolates to seven antimicrobial agents. The Journal of Antimicrobial Chemotherapy, 39, 135-140.

Rodriguez-Avial, I., Rodriguez-Avial, C., Culebras, E. and Picazo, J.J. (2003) Distribution of tetracycline resistance genes tet(M), tet(O), tet(L) and tet(K) in blood isolates of viridans group streptococci harbouring erm(B) and mef(A) genes. Susceptibility to quinupristin/dalfopristin and linezolid. International Journal of Antimicrobial Agents, 21, 536-541.

Rouff, K.L., Miller, S.I., Garner, C.V. et al. (1989) Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates. Journal of Clinical Microbiology, 27, 305-308.

Rudney, J.D. and Larson, C.J. (1993) Species identification of oral viridans streptococci by restriction fragment polymorphism analysis of rRNA genes. Journal of Clinical Microbiology, 31, 2467-2473.

Scannapieco, F.A., Wang, B. and Shiau, H.J. (2001) Oral bacteria and respiratory infection: effects on respiratory pathogen adhesion and epithelial cell proinflammatory cytokine production. Annals of Periodontology, 6, 78-86.

Schlegel, L., Grimont, F., Collins, M.D. etal. (2000) Streptococcus infantarius sp. nov., Streptococcus infantarius subsp. infantarius subsp. nov. and Streptococcus infantarius subsp. coli subsp. nov., isolated from humans and food. International Journal of Systematic and Evolutionary Microbiology, 50, 1425-1434.

Schlegel, L., Grimont, F., Ageron, E. etal. (2003a) Reappraisal of the taxonomy of the Streptococcus bovis/Streptococcus equinus complex and related species: description of Streptococcus gallolyticus subsp. gallolyticus subsp. nov., S. gallolyticus subsp. macedonicus subsp. nov. and S. gallolyticus subsp. pasteurianus subsp. nov. International Journal of Systematic and Evolutionary Microbiology, 53, 631-645.

Schlegel, L., Grimont, F., Grimont, P.A. and Bouvet, A. (2003b) Identification of major Streptococcal species by rrn-amplified ribosomal DNA restriction analysis. Journal of Clinical Microbiology, 41, 657-666.

Sciotti, M.A., Yamodo, I., Klein, J.P. and Ogier, J.A. (1997) The N-terminal half part of the oral streptococcal antigen I/IIf contains two distinct binding domains. FEMS Microbiology Letters, 153, 439-445.

Shain, H., Homer, K.A. and Beighton, D. (1996) Degradation and utilisation of chondroitin sulphate by Streptococcus intermedius. Journal of Medical Microbiology, 44, 372-380.

Shenep, J.L. (2000) Viridans-group streptococcal infections in immunocom-promised hosts. International Journal of Antimicrobial Agents, 14, 129-135.

Shinzato, T. and Saito, A. (1994) A mechanism of pathogenicity of "Streptococcus milleri group" in pulmonary infection: synergy with an anaerobe. Journal of Medical Microbiology, 40, 118-123.

Shinzato, T. and Saito, A. (1995) The Streptococcus milleri group as a cause of pulmonary infections. Clinical Infectious Diseases, 21, S238-S243.

Siegman-Igra, Y. and Schwartz, D. (2003) Streptococcus bovis revisited: a clinical review of 81 bacteremic episodes paying special attention to emerging antibiotic resistance. Scandinavian Journal of Infectious Diseases, 35, 90-93.

Simmons, N.A., Ball, A.P., Eykyn, S.J. etal. (1998) Antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis. Heart, 79, 207-210.

Strom, B.L., Abrutyn, E., Berlin, J.A. etal. (1998) Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study. Annals of Internal Medicine, 129, 761-769.

Teng, L.J., Hsueh, P.R., Ho, S.W. and Luh, K.T. (2001) High prevalence of inducible erythromycin resistance among Streptococcus bovis isolates in Taiwan. Antimicrobial Agents and Chemotherapy, 45, 3362-3365.

Trüper, H.G. and de'Clari, L. (1997) Taxonomic note: necessary correction of specific epithets formed as substantives (nouns) "in apposition". International Journal of Systematic Bacteriology, 47, 908-909.

Trüper, H.G. and de'Clari, L. (1998) Taxonomic note: erratum and correction of further specific epithets formed as substantives (nouns) "in apposition". International Journal of Systematic Bacteriology, 48, 615.

Unsworth, P.F. (1989) Hyaluronidase production in Streptococcus milleri in relation to infection. Journal of Clinical Pathology, 42, 506-510.

van der Meer, J.T., Thompson, J., Valkenburg, H.A. and Michel, M.F. (1992) Epidemiology of bacterial endocarditis in The Netherlands. II. Antecedent procedures and use of prophylaxis. Archives of Internal Medicine, 152, 1869-1873.

Venditti, M., Baiocchi, P., Santini, C. etal. (1989) Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients. Antimicrobial Agents and Chemotherapy, 33, 580-582.

Vernier, A., Diab, M., Soell, M. etal. (1996) Cytokine production by human epithelial and endothelial cells following exposure to oral viridans streptococci involves lectin interactions between bacteria and cell surface receptors. Infection and Immunity, 64, 3016-3022.

Viscount, H.B., Munro, C.L., Burnette-Curley, D. etal. (1997) Immunization with FimA protects against Streptococcus parasanguis endocarditis in rats. Infection and Immunity, 65, 994-1002.

Vriesema, A.J., Dankert, J. and Zaat, S.A. (2000) A shift from oral to blood pH is a stimulus for adaptive gene expression of Streptococcus gordonii CH 1 and induces protection against oxidative stress and enhanced bacterial growth by expression of msrA. Infection and Immunity, 68, 1061-1068.

Wells, V.D., Munro, C.L., Sulavik, M.C. etal. (1993) Infectivity of a glucan synthesis-defective mutant of Streptococcus gordonii (Challis) in a rat endocarditis model. FEMS Microbiology Letters, 112, 301-305.

Westling, K., Ljungman, P., Thalme, A. and Julander, I. (2002) Streptococcus viridans septicaemia: a comparison study in patients admitted to the departments of infectious diseases and haematology in a university hospital. Scandinavian Journal of Infectious Diseases, 34, 316-319.

Whatmore, A.M. and Whiley, R.A. (2002) Re-evaluation of the taxonomic position of Streptococcus ferus. International Journal of Systematic and Evolutionary Microbiology, 52, 1783-1787.

Whiley, R.A. and Beighton, D. (1991) Emended descriptions and recognition of Streptococcus constellatus, Streptococcus intermedius, and Streptococcus anginosus as distinct species. International Journal of Systematic Bacteriology, 41, 1-5.

Whiley, R.A. and Beighton, D. (1998) Current classification of the oral streptococci. Oral Microbiology and Immunology, 13, 195-216.

Whiley, R.A., Freemantle, L., Beighton, D. etal. (1993) Isolation, identification and prevalence of Streptococcus anginosus, S. intermedius, and S. constellatus from the human mouth. Microbial Ecology in Health and Disease, 6, 285-291.

Willcox, M.D. (1995) Potential pathogenic properties of members of the "Streptococcus milleri" group in relation to the production of endocarditis and abscesses. Journal of Medical Microbiology, 43, 405-410.

Willcox, M.D., Loo, C.Y., Harty, D.W. and Knox, K.W. (1995) Fibronectin binding by Streptococcus milleri group strains and partial characterisation of the fibronectin receptor of Streptococcus anginosus F4. Microbial Pathogenesis, 19, 129-137.

Willcox, M.D., Oakey, H.J., Harty, D.W. etal. (1994) Lancefield group C Streptococcus milleri group strains aggregate human platelets. Microbial Pathogenesis, 16, 451-457.

Wilson, W.R., Geraci, J.E., Wilkowske, C.J. and Washington, J.A. (1978) Short-term intramuscular therapy with procaine penicillin plus streptomycin for infective endocarditis due to viridans streptococci. Circulation, 57, 1158-1161.

Wisplinghoff, H., Reinert, R.R., Cornely, O. and Seifert, H. (1999) Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients. Journal of Clinical Microbiology, 37, 1876-1880.

Yokota, M., Basi, D.L., Herzberg, M.C. and Meyer, M.W. (2001) Anti-fibrin antibody binding in valvular vegetations and kidney lesions during experimental endocarditis. Microbiology and Immunology, 45, 699-707.

Young, S.E.J. (1987) Aetiology and epidemiology of infective endocarditis in England and Wales. The Journal of Antimicrobial Chemotherapy, 20(Suppl. A), 7-14.

Zhu, H., Willcox, M.D. and Knox, K.W. (2000) A new species of oral Streptococcus isolated from Sprague-Dawley rats, Streptococcus orisratti sp. nov. International Journal of Systematic and Evolutionary Microbiology, 50, 55-61.

0 0

Post a comment